Talen Energy
TLN
$343.12
-1.64%
Talen Energy is an independent power producer and energy infrastructure company that owns and operates a multi-gigawatt U.S. generation fleet, including roughly 2.2 GW of nuclear capacity anchored by the Susquehanna plant, alongside a dispatchable natural gas and coal portfolio selling electricity, capacity, and ancillary services into wholesale markets, principally PJM with additional assets in Ohio and Montana. Talen occupies a distinctive position as a pure-play merchant generator with scarce nuclear baseload in the supply-constrained PJM market, giving it leveraged exposure to rising capacity prices and the structural power demand created by data-center and AI buildouts rather than the regulated, rate-base economics of a traditional utility. The investor narrative has swung violently between these poles: enthusiasm over nuclear scarcity value and hyperscaler power deals (a 12.4% single-day surge in early October was attributed to nuclear-sector momentum following the Google-Constellation agreement) has collided with anxiety over a roughly $9.7 billion debt load, negative reported earnings, and a 33% three-month drawdown tied to cash-flow and leverage concerns. The recent completion of the Western PJM generation acquisition, described as immediately accretive to free cash flow per share and interest-expense reducing, is now the central execution test for the bull case.…
TLN
Talen Energy
$343.12
Related headlines
Investment Opinion: Should I buy TLN Today?
Rating: Hold with a constructive bias. The core thesis is that TLN offers scarce nuclear baseload in a supply-constrained PJM market at a 10.58x forward PE, but the $9.7 billion debt load and unproven free-cash-flow bridge mean investors should wait for execution evidence rather than pay for the story — a view anchored by the strong-buy consensus (mean 1.5) and $457.32 average target that imply 39.5% upside but have not been validated by reported earnings.
The supporting evidence is genuinely mixed. On the positive side, Q2 2026 revenue grew 64.54% YoY to $747 million, gross margin expanded to 49.26% from 20.70% a year earlier, TTM free cash flow of $510 million yields roughly 3.0% on the $17.1 billion market cap, and the Western PJM deal adds nearly $1.00 to FCF per share while reducing interest expense. On the negative side, trailing EPS is -$0.013, Q2 net income was -$92 million on $214 million of interest expense, Q2 free cash flow was -$546 million, ROE is -20.04%, and the stock trades at 6.52x sales and 45.31x EV/EBITDA — a premium that requires the forward EPS of $51.13 to be delivered.
The biggest risks that could invalidate the thesis are a second consecutive negative free-cash-flow quarter, a PJM capacity auction disappointment, and failure to de-lever the 6.24x debt-to-equity balance sheet. This Hold would upgrade to Buy if TLN posts positive free cash flow in Q3 2026 and demonstrates interest coverage improving from the current level, or if the price falls toward the $307 analyst low target while the forward EPS estimate holds; it would downgrade to Sell if free cash flow stays negative for another quarter or if consensus FY EPS of $51.13 is cut materially. On valuation, the stock is cheaper than its own history on sales (6.52x versus 23.61x in Q2 2026) but still priced for a successful earnings inflection, leaving it roughly fairly valued to modestly undervalued only if execution delivers.
Sign up to view all
TLN 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Talen Energy's 12-month outlook, with a consensus price target around $452.62 and implied upside of +31.9% versus the current price.
Average Target
$452.62
0 analysts
Implied Upside
+31.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$307 - $560
Analyst target range
Coverage is deep and overwhelmingly bullish: 20 analysts cover TLN with a consensus recommendation of "strong buy" (mean rating of 1.5 on a 1-5 scale), and an average target price of $457.32. Against the current price of $327.91, that implies roughly +39.5% upside to consensus, a gap that is unusually wide and signals that sell-side models are anchored to the forward EPS estimate of $51.13 and the accretion story rather than the recent price action. Institutional ratings show persistent conviction, with Morgan Stanley reiterating Overweight as recently as September 18, 2026, and Wells Fargo, Barclays, and Jefferies maintaining constructive stances through the summer, though Jefferies and Scotiabank sit at Hold/Sector Perform, indicating the bullishness is not unanimous.
The target range of $307 to $560 is exceptionally wide, spanning roughly 82% of the current price, which itself is a signal of high uncertainty rather than strong conviction. The $560 high target implies multiple expansion on top of the forward earnings recovery, likely assuming successful integration of the Western PJM assets, rising PJM capacity prices, and potentially new hyperscaler or data-center power agreements that monetize the nuclear fleet at premium contract prices. The $307 low target, essentially at today's price, prices in margin compression, sustained high interest costs on the ~$9.7 billion debt load, and disappointment on cash-flow conversion. The dispersion between the $457 average and the $307 low, combined with the stock trading near the bottom of its 52-week range despite a strong-buy consensus, suggests the market is discounting the sell-side view and waiting for tangible free-cash-flow evidence before re-rating the shares.
Bulls vs Bears: TLN Investment Factors
The bear case currently has stronger evidence because it rests on reported numbers — a $9.7 billion debt load, $214 million of quarterly interest expense, a Q2 net loss of $92 million, and negative Q2 free cash flow of -$546 million — while the bull case rests on a forward EPS estimate of $51.13 that has not yet materialized in any trailing period. The bulls' strongest card is the 39.5% upside to the $457.32 consensus target and the 10.58x forward PE, but those are only as credible as the earnings bridge they assume. The single most important tension is whether the Western PJM acquisition plus rising PJM capacity prices can convert into durable free cash flow per share fast enough to service and de-lever the balance sheet — if that bridge holds, the stock is deeply undervalued at 10.58x forward earnings; if it slips, the 45.31x EV/EBITDA and 6.52x PS leave substantial downside toward the $279.77 low. The 12.4% October 6 spike and subsequent 12% fade to $327.91 encapsulate this: the market wants to believe the nuclear scarcity story but is not yet willing to pay for it without cash-flow proof.
Bullish
- Nuclear scarcity in constrained PJM: TLN owns roughly 2.2 GW of nuclear capacity anchored by Susquehanna, a scarce baseload asset in a supply-constrained PJM market where capacity prices are structurally rising. This scarcity value is what drove the 12.4% single-day surge on October 6, 2026 (from $331.87 to $373.11) following the Google-Constellation nuclear agreement, demonstrating how quickly the market re-prices this asset on sector news.
- Consensus targets imply 39.5% upside: All 20 covering analysts carry a strong-buy consensus (mean rating 1.5) with an average target of $457.32 versus the $327.91 price, implying roughly +39.5% upside. Morgan Stanley reiterated Overweight as recently as September 18, 2026, and the $560 high target implies meaningful multiple expansion on top of the forward earnings recovery.
- Forward PE of 10.58x on $51.13 EPS: Consensus FY EPS of $51.13 against a $327.91 price yields a forward PE of just 10.58x, and the PEG ratio of 0.62 suggests the implied growth rate makes that multiple cheap if estimates are met. The market is pricing a dramatic earnings inflection from the trailing EPS of -$0.013, and the Western PJM deal is the bridge to that inflection.
- Western PJM deal is FCF accretive: The completed Western PJM acquisition was characterized by management as immediately accretive, adding nearly $1.00 to free cash flow per share and significantly reducing annual interest expenses. Regulatory clearances for the Lawrenceburg, Waterford and Darby assets removed the major deal uncertainty, and TTM free cash flow of $510 million against a $17.1 billion market cap already yields roughly 3.0%.
Bearish
- $9.7 billion debt consuming earnings: Debt-to-equity stands at 6.24x with total debt to capitalization at 85.56%, and Q2 2026 interest expense alone was $214 million against operating income of -$72 million. The interest burden is the direct cause of the net loss of $92 million (EPS -$2.00) despite a respectable 49.26% gross margin, meaning equity holders are levered to a thin residual after creditors.
- Erratic, mostly negative earnings record: The quarterly record swings violently: Q1 2026 earned $63 million (EPS $1.33), Q2 2026 lost $92 million (EPS -$2.00), and Q4 2025 lost $363 million (EPS -$7.70) with EBITDA of -$184 million. Trailing operating margin is 0.61% and net margin -8.34%, with ROE of -20.04%, so the forward EPS of $51.13 requires a step-change that has not yet appeared in reported results.
- Negative free cash flow in Q2: Q2 2026 operating cash flow was -$434 million and free cash flow -$546 million, driven by a $598 million working capital drain plus $112 million of capex, even though Q1 generated $461 million of operating cash flow. This cash-flow volatility is precisely what the market is punishing, and it undermines the deleveraging narrative that the bull case depends on.
- Severe relative underperformance: TLN is down 14.57% over one year and 17.35% YTD versus the S&P 500's +13.13% and +11.45%, producing relative strength of -27.70% over twelve months and -28.80% YTD. The stock sits at roughly 28% of its 52-week range ($279.77-$449.84), about 27% below the high, with a max drawdown of -36.71% confirming sustained capital destruction for recent buyers.
TLN Technical Analysis
TLN is in a damaged but stabilizing downtrend: the stock is down 14.57% over the past year and 17.35% year-to-date, a stark underperformance versus the S&P 500's +13.13% one-year and +11.45% YTD returns, producing relative strength of -27.70% over twelve months. At $327.91, the stock sits at roughly 28% of its 52-week range of $279.77 to $449.84, meaning it trades in the lower third of the band, about 27% below the high and 17% above the low. That positioning reflects a market that has de-rated the shares from momentum leadership into a show-me phase, where the burden of proof has shifted to cash-flow delivery and deleveraging rather than multiple expansion. The maximum drawdown of -36.71% confirms this has been a high-pain holding for anyone who bought near the highs.
Short-term momentum has turned constructive even as the longer-term trend remains negative, a classic divergence. The stock is up 9.18% over the past month against a -1.02% decline in SPY, generating +10.20% relative strength over that window, and the early-October spike from $331.87 on October 5 to $373.11 on October 6 (+12.4%) shows how violently the shares can re-rate on nuclear-sector headlines. However, that rally has already faded: the stock closed at $327.91 on October 23, down 1.06% on the day and roughly 12% below the October 13 close of $382.14, while the three-month change of -8.89% and six-month change of -9.99% show the intermediate trend is still downward. The pattern of sharp rallies followed by retracement suggests buyers are defending the low-$300s but lack conviction to chase strength, and the 3.0 short ratio indicates short interest is meaningful but not extreme.
Key technical levels are well defined. Support sits at the 52-week low of $279.77, with the September consolidation zone around $282-$287 acting as a secondary floor; a breakdown below $279.77 would signal that the market is pricing in a fundamental deterioration beyond the current cash-flow debate and could open a deeper leg lower. Resistance is anchored at the 52-week high of $449.84, with intermediate supply at the October swing high near $382 and the June peak of $438.12; a decisive breakout above $382 on volume would be the first evidence of a trend reversal, while reclaiming $400+ would confirm it. With a beta of 1.617, TLN is roughly 62% more volatile than the market, meaning position sizing should be materially smaller than a market-weight allocation and stop-loss discipline is essential given the stock's demonstrated ability to move 12% in a single session.
Beta
1.62
1.62x market volatility
Max Drawdown
-36.7%
Largest decline past year
52-Week Range
$280-$450
Price range past year
Annual Return
-12.4%
Cumulative gain past year
| Period | TLN Return | S&P 500 |
|---|---|---|
| 1m | +9.7% | -0.9% |
| 3m | +2.7% | +1.2% |
| 6m | -7.8% | +4.9% |
| 1y | -12.4% | +11.2% |
| ytd | -13.5% | +10.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
TLN Fundamental Analysis
Revenue is growing rapidly but unevenly. Q2 2026 revenue of $747 million represented 64.54% year-over-year growth versus $454 million in Q2 2025, though it declined sequentially from Q1 2026's $1.241 billion, reflecting the seasonal and commodity-sensitive nature of merchant power sales. The revenue mix is dominated by electricity and ancillary services at $626 million, with capacity revenue of $237 million and bilateral/physical sales of $31 million, partially offset by a $6 million unrealized loss on commodity contracts; the PJM segment generates the overwhelming majority of revenue. The trajectory is supported by the completed Western PJM acquisition, which management characterized as immediately accretive to free cash flow per share, but the sequential volatility underscores that headline growth is partly price-and-weather driven rather than purely structural.
Profitability is the weak link. Q2 2026 produced a net loss of $92 million (EPS of -$2.00) on a 49.26% gross margin, with operating income of -$72 million and a net margin of -12.32%, driven by $214 million of interest expense and $342 million of other expenses. The quarterly record is highly erratic: Q1 2026 earned $63 million (EPS $1.33) at a 39.40% gross margin, while Q4 2025 lost $363 million (EPS -$7.70) with EBITDA of -$184 million. Trailing operating margin is a razor-thin 0.61% and net margin -8.34%, and the TTM EPS of -$0.013 shows the company is essentially at breakeven on a trailing basis despite a 38.12% gross margin. For an independent power producer, gross margins in the high-30s to high-40s are respectable, but the interest burden is consuming the operating economics.
Balance sheet leverage is the central risk. Debt-to-equity stands at 6.24x, total debt to capitalization is 85.56%, and the company carries roughly $9.7 billion of debt, with Q2 2026 interest expense of $214 million alone. Liquidity is adequate but not generous: current ratio of 1.28, cash of $238 million at quarter-end, and TTM free cash flow of $510 million against a market cap of $17.1 billion (FCF yield of roughly 3.0%). Q2 operating cash flow was -$434 million and free cash flow -$546 million, reflecting a $598 million working capital drain and $112 million of capex, though the prior quarter generated $461 million of operating cash flow. ROE of -20.04% and ROA of 0.92% confirm that returns are being eroded by the capital structure; the company is funding its acquisition strategy with debt (senior notes priced in April 2026) rather than internal cash, which amplifies both upside and downside.
Quarterly Revenue
$747000000.0B
2026-06
Revenue YoY Growth
+64.5%
YoY Comparison
Gross Margin
49.3%
Latest Quarter
Free Cash Flow
$510000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is TLN Overvalued?
Because trailing net income is negative (TTM EPS of -$0.013, trailing PE of -78.25x), the PE ratio is not meaningful and I am leading with the forward PE and EV/EBITDA framework. The forward PE of 10.58x against consensus FY EPS of $51.13 implies the market expects a dramatic earnings inflection from roughly breakeven trailing levels, while the EV/EBITDA of 45.31x and EV/Sales of 6.75x show that on an enterprise basis the stock is not cheap. The enormous gap between trailing and forward earnings multiples signals that the market is pricing in either a step-change in PJM capacity revenues, accretion from the Western PJM deal, or both, and the credibility of that bridge is the entire valuation debate.
Against utility and IPP peers, TLN screens as a premium asset on sales-based metrics: PS of 6.52x and EV/Sales of 6.75x are well above what regulated utilities typically command (generally 2-4x sales), reflecting the scarcity premium assigned to nuclear baseload and data-center-adjacent generation. The PB ratio of 15.67x is extreme and reflects a thin book equity base rather than operational excellence, while the PEG ratio of 0.62 suggests the forward earnings growth rate is high enough to make the forward multiple look reasonable if estimates are met. The premium is defensible only if the nuclear fleet's contracted and capacity revenues deliver the earnings implied by consensus; if PJM pricing or contract execution disappoints, the sales multiple offers little cushion.
Historically, TLN's valuation has compressed dramatically from its post-listing levels. The PS ratio was 23.61x in Q2 2026 and 22.21x in Q4 2025, versus 6.52x today, and the PB ratio has ranged from 1.54x in Q4 2023 to 15.67x now, with the current reading near the top of that band even as the stock price has fallen. The forward PE of 10.58x compares favorably to the trailing figures, but the historical PE series is distorted by negative and near-zero earnings quarters. Net-net, the stock is cheaper than it was a year ago on sales but still priced for a successful earnings inflection, leaving limited margin of safety if execution slips.
PE
-78.3x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 1x~58x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
45.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are dominated by the capital structure. Total debt of roughly $9.7 billion against debt-to-equity of 6.24x and total debt to capitalization of 85.56% means Q2 2026 interest expense of $214 million consumed the entire quarter's operating economics, producing a net loss of $92 million despite a 49.26% gross margin. Cash conversion is unreliable — Q2 operating cash flow was -$434 million and free cash flow -$546 million on a $598 million working capital drain — and the company funded its Western PJM acquisition with senior notes priced in April 2026 rather than internal cash, so leverage rises before it falls. Revenue is also concentrated in PJM merchant power, where Q2 revenue of $747 million fell sequentially from Q1's $1.241 billion, showing that headline 64.54% YoY growth is partly price-and-weather driven rather than contracted.
Market and competitive risks center on valuation compression and merchant power exposure. At PS of 6.52x, EV/Sales of 6.75x, and EV/EBITDA of 45.31x, TLN trades at a scarcity premium to regulated utilities (typically 2-4x sales) that depends on data-center and AI power demand materializing at premium contract prices; if hyperscaler deals stall or PJM capacity auctions disappoint, that premium can compress sharply. The beta of 1.617 means TLN is roughly 62% more volatile than the market, amplifying sector rotation out of power and AI-adjacent names — the Zacks coverage explicitly frames TLN as a high-risk play in the competitive data-center power market, and the 33.3% three-month decline was attributed to cash-flow and debt concerns rather than any operational failure. Competitive threats include other IPPs and nuclear operators (the Google-Constellation agreement that lifted TLN also validates rivals' scarcity value) and the risk that new capacity or demand response erodes PJM pricing power.
The worst-case scenario is a cash-flow disappointment that forces the market to abandon the forward EPS bridge. If Q3 or Q4 2026 shows another negative free cash flow quarter, consensus FY EPS of $51.13 gets cut, the 10.58x forward PE re-rates toward the trailing reality, and the stock retests its 52-week low of $279.77 — a decline of roughly -14.7% from $327.91. A break below that level, given the -36.71% max drawdown already experienced and the $307 analyst low target sitting essentially at today's price, could open a deeper leg toward the $282-$287 September consolidation zone, implying losses of roughly -12% to -15% in the base adverse case and more if the low fails. With a 3.0 short ratio and demonstrated 12% single-session moves, an adverse headline could compress the price toward the low target quickly, so position sizing must reflect a realistic -15% to -25% downside band.
FAQ
The most severe risk is financial: $9.7 billion of debt at 6.24x debt-to-equity with $214 million of Q2 interest expense produced a $92 million net loss despite a 49.26% gross margin, and Q2 free cash flow of -$546 million shows cash conversion is unreliable. Second is earnings volatility: quarterly EPS has swung from $1.33 in Q1 2026 to -$2.00 in Q2 2026 to -$7.70 in Q4 2025, so the $51.13 forward estimate carries real execution risk. Third is valuation compression: EV/EBITDA of 45.31x and PS of 6.52x embed a scarcity premium that could unwind if PJM capacity auctions disappoint or hyperscaler power deals stall. Fourth is market sensitivity: a beta of 1.617 means TLN amplifies sector rotation out of AI-adjacent power names, as shown by the -36.71% max drawdown and -27.70% one-year relative strength.
The 12-month outlook has three scenarios. The base case (50% probability) targets $380-$457, assuming consensus EPS of $51.13 is broadly met, free cash flow turns modestly positive, and the stock grinds back toward the $457.32 average target. The bull case (25%) targets $457-$560, requiring PJM capacity prices to clear higher, a new hyperscaler contract for Susquehanna, and positive free cash flow validating multiple expansion toward the $560 high target. The bear case (25%) targets $279-$307, driven by another negative free-cash-flow quarter, an EPS cut, and a retest of the $279.77 52-week low. The base case is most likely because the Western PJM accretion is already contracted and the forward PE of 10.58x provides support, but the key assumption — that Q2's -$546 million free cash flow reverses — remains unproven.
TLN is priced for an earnings inflection rather than current fundamentals. The trailing PE of -78.25x is meaningless given trailing EPS of -$0.013, so the relevant metric is the 10.58x forward PE on $51.13 consensus EPS, which looks cheap, supported by a 0.62 PEG. However, on enterprise metrics the stock is not cheap: EV/EBITDA of 45.31x, EV/Sales of 6.75x, and PS of 6.52x are well above the 2-4x sales typical of regulated utilities, reflecting a scarcity premium for nuclear baseload. The PS has compressed from 23.61x in Q2 2026 to 6.52x today, so the stock is cheaper than its own history on sales, but the PB of 15.67x sits near the top of its historical band. Net-net, the market is paying a premium that implies successful Western PJM integration and rising PJM capacity prices — fairly valued if those deliver, overvalued if they slip.
From a risk/reward perspective, TLN offers roughly 39.5% upside to the $457.32 consensus target against downside to the $307 analyst low target (about -6%) and the $279.77 52-week low (about -15%), a favorable ratio on paper. The catch is that the upside depends on delivering $51.13 of forward EPS against trailing EPS of -$0.013, while Q2 free cash flow was -$546 million and interest expense was $214 million. The strong-buy consensus (1.5 mean across 20 analysts) and 10.58x forward PE are attractive, but the stock's -27.70% one-year relative strength shows the market is not yet convinced. It is a good buy for risk-tolerant investors with a multi-year horizon who want leveraged exposure to PJM capacity prices and nuclear scarcity, ideally accumulating near the $307-$310 support zone rather than chasing the 12.4% October 6 spike.
TLN is better suited to long-term holding with active risk management than to short-term trading. The long-term case rests on structural PJM capacity tightness, 2.2 GW of scarce nuclear baseload, and data-center power demand, but the path is volatile: beta of 1.617, a -36.71% max drawdown, and a demonstrated 12.4% single-day move on October 6, 2026 make short-term trading a headline-driven gamble. There is no dividend (yield 0%, payout ratio 0), so returns depend entirely on capital appreciation and earnings delivery, and earnings visibility is low given quarterly EPS swings from $1.33 to -$7.70. A suggested minimum holding period of 18-24 months allows time for Western PJM accretion, PJM capacity repricing, and de-leveraging to show in free cash flow, with position sizing materially below market weight and a stop discipline around the $279.77 low.